The PGA TOUR Champions returns to Mission Hills Country Club March 26-30 for the third-annual Galleri Classic Presented by Spotlight 29 Casino. The tournament will bring the 50+ tour’s top talents back to the desert and shine a light on advances in cancer diagnosis through Galleri, a multi-cancer early detection (MCED) blood test.

Past tournament standouts, including 2023 champion David Toms, reigning champion Retief Goosen and two-time runner-up Steven Alker will join Bernhard Langer, Stewart Cink, Miguel Angel Jimenez, Colin Montgomerie and Galleri player ambassador Steve Stricker, to name a few.

Further empowering the fight against cancer, The Galleri Classic will once again benefit local organizations supporting individuals along their cancer journey: American Cancer Society, The Desert Cancer Foundation, Eisenhower Health, Hanson House, Pendleton Foundation and Shay’s Warriors Life After Cancer.

Early cancer detection is proven to save lives and Galleri’s parent company GRAIL is a leader in the global effort to enhance screening standards. They are currently conducting multiple clinical studies including those with England’s National Health Services and Medicare to enroll more than 385,000 participants globally.¹

The Galleri test can be taken annually as a simple blood test and screens for a “fingerprint” of many of the deadliest cancers before they become symptomatic, including those with no recommended screening tests today such as pancreatic, esophageal, ovarian, liver and others.² Positive results are followed by subsequent medical testing to confirm that a cancer is truly present helping to eliminate the possibility of a false positive.

We reached out to Director of Communications Tina Amirkiai for the latest on GRAIL’s clinical trials:

GRAIL has completed more than 290,000 commercial tests in the U.S.
Their clinical implementation study, PATHFINDER, showed that Galleri identified more than twice the number of cancers when added to standard-of-care screening. About half of the MCED-detected cancers were at an early stage. About seven in 10 of the MCED-detected cancers had no other standard-of-care screening available. The positive predictive value in the study population was
43 percent, an order of magnitude higher than those of the leading single-cancer screenings.³
Later this year, GRAIL will present foundational data, including the early results from their 35,000-participant PATHFINDER 2 study.⁴
In 2026, they expect final data from the longitudinal 140,000-participant
NHS-Galleri study in the UK.
GRAIL now has over 12,000 prescribing physicians nationally with 40 clinics here in the Coachella Valley including their partnership with the Comprehensive Cancer Center at Desert Regional Medical Center.
They are progressing in their modular premarket approval (PMA) submission for FDA approval and expect final submission to be in the first half of 2026.

“Hopefully, multi-cancer early tests will soon be an everyday occurrence in our lives,” says Timothy Tyler, MD, director of pharmacy, lab and oncology at the Comprehensive Cancer Center. “Personally, I’d much rather spend money finding a cancer early, when it is easy to remove, rather than spend a tremendous amount more trying to treat it, when it finally starts causing symptoms.”

The Galleri test requires a prescription from a licensed health care provider and is recommended for adults with an elevated risk for cancer, such as those aged 50 or older. At this year’s Galleri Classic, GRAIL will not have their mobile phlebotomy lab on site, but will offer attendees $100 off the cost of the test which is currently out-of-pocket. The Galleri test should be used in addition to recommended cancer screenings such as mammography, colonoscopy, prostate-specific antigen (PSA) test or cervical cancer screening.

If you’re 50+, come see the legendary players you’ve enjoyed watching for decades at The Galleri Classic, and learn more about the Galleri test as part of your proactive health care plan.

The Galleri Classic takes place March 26-30 at Mission Hills Country Club in Rancho Mirage. Tickets start at $30 and are available at www.TheGalleriClassic.com. For more information on the Galleri test, visit www.Galleri.com.

References: 1) https://clinicaltrials.gov/study/NCT05673018; 2) https://www.galleri.com/what-is-galleri; 3) https://cancerworld.net/multi-cancer-detection-blood-test; 4) https://clinicaltrials.gov/study/NCT05155605